MDT

88.02

+0.36%↑

A

120.93

+3.42%↑

VEEV

157.02

-0.17%↓

HQY

80.21

+0.54%↑

TLRY

6.89

+2.53%↑

MDT

88.02

+0.36%↑

A

120.93

+3.42%↑

VEEV

157.02

-0.17%↓

HQY

80.21

+0.54%↑

TLRY

6.89

+2.53%↑

MDT

88.02

+0.36%↑

A

120.93

+3.42%↑

VEEV

157.02

-0.17%↓

HQY

80.21

+0.54%↑

TLRY

6.89

+2.53%↑

MDT

88.02

+0.36%↑

A

120.93

+3.42%↑

VEEV

157.02

-0.17%↓

HQY

80.21

+0.54%↑

TLRY

6.89

+2.53%↑

MDT

88.02

+0.36%↑

A

120.93

+3.42%↑

VEEV

157.02

-0.17%↓

HQY

80.21

+0.54%↑

TLRY

6.89

+2.53%↑

Search

ResMed Inc

Open

SectorHealthcare

229.79 0.18

Overview

Share price change

24h

Current

Min

228.84

Max

232

Key metrics

By Trading Economics

Income

44M

393M

Sales

87M

1.4B

P/E

Sector Avg

22.248

66.418

Dividend yield

1.01

Profit margin

27.593

Employees

10,600

EBITDA

63M

566M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+25.04% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.01%

2.36%

Next Earnings

30 Apr 2026

Next Dividend date

11 Jun 2026

Next Ex Dividend date

7 May 2026

Market Stats

By TradingEconomics

Market Cap

-4.5B

33B

Previous open

229.61

Previous close

229.79

News Sentiment

By Acuity

22%

78%

49 / 348 Healthcare

ResMed Inc Chart

Past performance is not a reliable indicator of future results.

Related News

13 Apr 2026, 23:25 UTC

Major News Events

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy -- Update

13 Apr 2026, 22:45 UTC

Major News Events

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy

13 Apr 2026, 18:03 UTC

Earnings

Louis Vuitton Owner Logs Weak Sales as Middle East War Takes Toll -- 2nd Update

13 Apr 2026, 23:58 UTC

Earnings

Review & Preview: Earnings Time -- Barrons.com

13 Apr 2026, 23:49 UTC

Market Talk

Nikkei May Rise After Overnight Gains on Wall Street -- Market Talk

13 Apr 2026, 23:33 UTC

Market Talk
Major News Events

Gold Edges Higher Amid Dollar Weakness -- Market Talk

13 Apr 2026, 23:20 UTC

Market Talk

Uranium Stocks Seen Benefiting From Energy Security Concerns -- Market Talk

13 Apr 2026, 23:01 UTC

Earnings

Aura: Capex Guidance Revised From $111M and $130M to New Range of $262M and $314M >AURA33.SA.BR

13 Apr 2026, 23:01 UTC

Earnings

Aura Minerals: Announces Update to Capex Guidance Including Construction of the Era Dorada Project

13 Apr 2026, 23:01 UTC

Earnings

Aura: Will Update Cap Expenditure Guidance to Include the Project's Construction Phase >AURA33.SA.BR

13 Apr 2026, 22:21 UTC

Acquisitions, Mergers, Takeovers

Chevron Swaps Offshore Gas Stakes to Boost Venezuelan Heavy-Oil Footprint -- Update

13 Apr 2026, 21:53 UTC

Earnings

MarketWise, Inc.: Affirms FY 2026 Guidance, Including Div Target to Class A Hldrs of $1.80 per Shr

13 Apr 2026, 21:53 UTC

Earnings

MarketWise, Inc.: Paid Subscribers Were 381,000 at March 31 Compared to 374,000 at Dec 31, 2025, Active Free Subscribers Were 2.0M at March 31 >MKTW

13 Apr 2026, 21:53 UTC

Earnings

MarketWise, Inc.: 1Q Billings Increased Approximately 15% Yr-over-Yr to Approximately $81M

13 Apr 2026, 21:53 UTC

Earnings

MarketWise, Inc.: Preliminary Selected Unaudited 1Q Paid Subscribers Returning to Growth

13 Apr 2026, 21:26 UTC

Major News Events

U.S. Oil Blockade Is Set to Boost American Exports -- and Prices at the Pump -- WSJ

13 Apr 2026, 21:23 UTC

Earnings

Johnson & Johnson Earnings: Oncology Powers Growth, but Talc Lawsuits Persist -- Barrons.com

13 Apr 2026, 21:16 UTC

Earnings

Goldman Sachs Reports Record Quarter in Banking and Trading -- 4th Update

13 Apr 2026, 20:50 UTC

Market Talk
Major News Events

Basic Materials Roundup: Market Talk

13 Apr 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

13 Apr 2026, 20:34 UTC

Earnings

Victory Capital: 1Q Long-Term AUM Net Flows of -$457M >VCTR

13 Apr 2026, 20:34 UTC

Earnings

Victory Capital: March Avg Total AUM Was $315.3B, Avg Other Assets $3.2B, Avg Total Client Assets $318.5B >VCTR

13 Apr 2026, 20:34 UTC

Earnings

Victory Capital Holdings, Inc.: Total Assets Under Management of $309.8B, Other Assets $3.3B, Total Client Assets of $313.1B as of March 31 >VCTR

13 Apr 2026, 19:59 UTC

Market Talk

Canada Consumers Sour Prior to Big Energy-Price Jump -- Market Talk

13 Apr 2026, 19:50 UTC

Market Talk
Major News Events

Oil Futures Pull Back From Highs on Hopes for Talks -- Market Talk

13 Apr 2026, 19:27 UTC

Market Talk
Major News Events

Correction to Precious Metals Market Talk on April 9

13 Apr 2026, 19:14 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower on Mild Weather -- Market Talk

13 Apr 2026, 18:59 UTC

Market Talk
Major News Events

Fed's Goolsbee: Don't Be Surprised If Consumer Confidence Sours -- Market Talk

13 Apr 2026, 18:59 UTC

Market Talk
Major News Events

Fed's Goolsbee: Oil Shows People Expect Short Term Conflict in Iran -- Market Talk

13 Apr 2026, 18:43 UTC

Market Talk

Precious Metals Lose Ground as U.S. Blockade in Hormuz Gets Underway -- Market Talk

Peer Comparison

Price change

ResMed Inc Forecast

Price Target

By TipRanks

25.04% upside

12 Months Forecast

Average 287.91 USD  25.04%

High 340 USD

Low 255 USD

Based on 13 Wall Street analysts offering 12 month price targets forResMed Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

13 ratings

8

Buy

5

Hold

0

Sell

Sentiment

By Acuity

49 / 348 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat